Core Viewpoint - The announcement from Keren Dental Hospital Co., Ltd. regarding the expected increase in related party transactions for 2026 to 55 million yuan, up from approximately 12.45 million yuan in 2025, raises concerns about the nature of its relationship with its main supplier, Shandong Haoya Medical Technology Co., Ltd. [1][2] Group 1: Related Party Transactions - Keren Dental expects its related party transactions to increase significantly in 2026, with an estimated amount of 55 million yuan compared to 12.45 million yuan in 2025, indicating a substantial growth in transaction volume and the number of related parties involved [1] - Shandong Haoya Medical has been a consistent top supplier for Keren Dental, ranking first among its suppliers since 2018, with transaction amounts reaching 23.64 million yuan that year, accounting for 83.69% of Keren Dental's annual procurement [1] Group 2: Supplier Relationships - Despite Keren Dental's claims of no related party relationship with Haoya Medical, various public records suggest numerous hidden connections between the two entities [2] - Haoya Medical's wholly-owned subsidiary, Shandong Yuanli Coral Medical Technology Co., Ltd., shares identical contact information with multiple companies controlled by Keren Dental's actual controller, Wan Shaohua [2][4] Group 3: Financial Performance - Keren Dental's 2024 annual report indicates a revenue of 419.99 million yuan, a decrease of 1.15% year-on-year, with a net profit attributable to shareholders dropping by 73.53% to 5.31 million yuan [10][12] - The company reported a cumulative procurement amount exceeding 90 million yuan from Haoya Medical over seven years, highlighting a long-term stable partnership [7] Group 4: Regulatory Concerns - Keren Dental has faced scrutiny for potential violations regarding the disclosure of related party transactions, with previous incidents of failing to timely disclose significant share pledges and freezes involving its controlling shareholder [16]